DrugInference: CYP450-Stoffwechselmodellierung, Polypharmazie-Graph-KI & Toxizitätsminderung

DrugInference liefert Plattformen für Hochdurchsatz-In-Silico-Pharmakologie auf Basis geometrischer Graph-Neural-Networks (GNNs), die Arzneimittel-Target-Bindungsaffinitäten (Kd/Ki), Off-Target-Interaktionen und klinische ADMET-Pharmakokinetik mit Sub-Ångström-Auflösung vorhersagen.

DrugInference Geometric Deep Learning & Pharmacological Pipeline

3D protein structure ingestion, equivariant neural docking core, and ADMET toxicity filter

Central System: Molecular Inference Core - Equivariant Graph Neural Network

Clinical IoMT Nodes

Target Protein Structural Ingestion
Equivariant Graph Neural Core
In-Silico Docking & Conformation Filter
ADMET Pharmacokinetics Predictor
Preclinical Candidate Notarizer

Architectural Layers & Regulatory Standards

Structural Biology & Pocket Featurization (PDBx/mmCIF Parsing / AlphaFold2/3 Coordinate Embeddings): Extracting chemical topology, electrostatic surfaces, and hydrophobic binding pockets from target proteins.
Equivariant Molecular Representation (SE(3) Equivariant Graph Transformers / E(n)-GNNs): Computing atomic coordinate representations that remain invariant under physical 3D rotations and translations.
Thermodynamic Free Energy & Affinity Inference (Monte Carlo Free Energy Perturbation / Deep Scoring): Predicting dissociation constants (Kd), inhibitory concentrations (IC50), and ligand binding poses.
In-Silico ADMET & Safety Screening (Multi-Task Graph Ensembles / hERG Channel Classifiers): Screening candidate compounds for cardiac cardiotoxicity, hepatotoxicity, metabolic clearance, and CYP450 inhibition.

Key Metrics: < 0.8 Å (Binding Pose Root-Mean-Square Deviation (RMSD)) | 100M / Day (Virtual Compound Screening Throughput) | 94.6% (Cardiotoxicity (hERG) Screening Accuracy) | OECD QSAR (Regulatory Validation Standard)

Pharmakologische KI-Inferenz, Wirkstoff-Ziel-Bindungsaffinität, In-silico-molekulares Docking und Toxizitätsscreening

Autoritative technische Referenz fuer pharmacological ai inference, drug-target binding affinity, in-silico molecular docking & toxicity screening gemaess FDA 510(k), EU MDR, IEC 62304 Klasse C Software-Lebenszyklus und IoMT-Interoperabilitaet.

Core Engineering Areas

Geometric Deep Learning Docking — Core clinical engineering and protocols for Geometric Deep Learning Docking.
In-Silico ADMET Screening — Core clinical engineering and protocols for In-Silico ADMET Screening.
Regulatory In-Silico Acceptance — Core clinical engineering and protocols for Regulatory In-Silico Acceptance.

Technical Articles

Related Cluster Architecture Specifications

HealthVigilance — Zero-Trust IoMT Architecture, SaMD Risk Engineering & Autonomous Clinical Post-Market Vigilance
AgenticSaMD — Autonomous Agentic Software as a Medical Device, Multi-Agent Clinical Decision Support & FDA GMLP Guardrails
AITelemonitoring — Autonomous AI Telemonitoring, Virtual Nursing Assistants & Predictive Clinical Deterioration Scoring
BCI2IoMT — Brain-Computer Interface IoMT Gateways, Neural Decoding & Electrophysiological Streaming